Literature DB >> 17315464

Ocular chlamydiales infections of western barred bandicoots (Perameles bougainville) in Western Australia.

Kristin Warren1, Ralph Swan, Tracey Bodetti, Tony Friend, Stephanie Hill, Peter Timms.   

Abstract

The western barred bandicoot (Perameles bougainville) is an endangered species, free ranging on only two islands off the coast of Western Australia (Dorre and Bernier Islands). Conservation efforts are currently directed at reintroducing these marsupials into predator-proof enclosures and habitats in historical distribution ranges on the mainland in the southwest of Western Australia and in South Australia. In September 2000, 19 western barred bandicoots were captured on Bernier Island for translocation, and 11 of these had evidence of at least one of the following eye conditions: corneal opacity, conjunctivitis, ocular discharge, and blepharitis. Five bandicoots were examined, and conjunctival and cloacal swabs were collected. Polymerase chain reaction for Chlamydiales was positive in four bandicoots. Four Chlamydiales types were identified by gene sequencing, including a strain of Chlamydia pecorum different from strains previously found in koalas and several new Chlamydiales genotypes. The bandicoots responded excellently to treatment with oxytetracyline weekly for 6 wk, and topical oxytetracycline and neomycin were administered topically to both eyes s.i.d. for 4 mo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 17315464     DOI: 10.1638/02-067

Source DB:  PubMed          Journal:  J Zoo Wildl Med        ISSN: 1042-7260            Impact factor:   0.776


  8 in total

1.  Isolation and antimicrobial susceptibilities of Chlamydial isolates from Western barred bandicoots.

Authors:  Swati Kumar; Andrei Kutlin; Patricia Roblin; Stephan Kohlhoff; Tracey Bodetti; Peter Timms; Margaret R Hammerschlag
Journal:  J Clin Microbiol       Date:  2006-11-22       Impact factor: 5.948

2.  Chlamydia pneumoniae is genetically diverse in animals and appears to have crossed the host barrier to humans on (at least) two occasions.

Authors:  Candice M Mitchell; Susan Hutton; Garry S A Myers; Robert Brunham; Peter Timms
Journal:  PLoS Pathog       Date:  2010-05-20       Impact factor: 6.823

Review 3.  Recent advances in the understanding of Chlamydophila pecorum infections, sixteen years after it was named as the fourth species of the Chlamydiaceae family.

Authors:  Khalil Yousef Mohamad; Annie Rodolakis
Journal:  Vet Res       Date:  2009-12-10       Impact factor: 3.683

4.  Transcriptome sequencing of the long-nosed bandicoot (Perameles nasuta) reveals conservation and innovation of immune genes in the marsupial order Peramelemorphia.

Authors:  Katrina M Morris; Haylee J Weaver; Denis O'Meally; Marion Desclozeaux; Amber Gillett; Adam Polkinghorne
Journal:  Immunogenetics       Date:  2017-11-20       Impact factor: 2.846

5.  Novel Chlamydiales genotypes identified in ticks from Australian wildlife.

Authors:  Delaney Burnard; Haylee Weaver; Amber Gillett; Joanne Loader; Cheyne Flanagan; Adam Polkinghorne
Journal:  Parasit Vectors       Date:  2017-01-26       Impact factor: 3.876

6.  Multiple Chlamydiaceae species in trachoma: implications for disease pathogenesis and control.

Authors:  Deborah Dean; Ram P Kandel; Him K Adhikari; Tracey Hessel
Journal:  PLoS Med       Date:  2008-01-03       Impact factor: 11.069

7.  Host adaptation of Chlamydia pecorum towards low virulence evident in co-evolution of the ompA, incA, and ORF663 Loci.

Authors:  Khalil Yousef Mohamad; Bernhard Kaltenboeck; Kh Shamsur Rahman; Simone Magnino; Konrad Sachse; Annie Rodolakis
Journal:  PLoS One       Date:  2014-08-01       Impact factor: 3.240

8.  Molecular evidence of Chlamydia pecorum and arthropod-associated Chlamydiae in an expanded range of marsupials.

Authors:  Delaney Burnard; Wilhelmina M Huston; Jonathan K Webb; Martina Jelocnik; Andrea Reiss; Amber Gillett; Sean Fitzgibbon; Scott Carver; Janine Carrucan; Cheyne Flanagan; Peter Timms; Adam Polkinghorne
Journal:  Sci Rep       Date:  2017-10-09       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.